MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Daiwa Securities Starts Merck & Co. at Neutral With $70 Price Target

12/16/2021 | 06:53am EDT


ę MT Newswires 2021
All news about MERCK & CO., INC.
09:03aCalliditas Therapeutics Starts Enrollment of Mid-Stage Head and Neck Cancer Study
MT
07:35aBerenberg Bank Adjusts Merck's Price Target to $95 From $87, Maintains Hold Rating
MT
05/16Neoleukin Therapeutics Treats First Tumor Patient in Trial Evaluating NL-201 With Keytr..
MT
05/16Athenex, Merck Collaborate to Study Oraxol Plus Keytruda in Non-Small Cell Lung Cancer
MT
05/16Rising Cyber Attacks Could Make Insurance Unaffordable
AQ
05/13Tesla, Occidental rise; New Relic, Merck fall
AQ
05/12Thinking about trading options or stock in Hess, Electronic Arts, Merck, Microsoft, or ..
PR
05/11TRANSCRIPT : Merck & Co., Inc. Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/10SECTOR UPDATE : Health Care Stocks Still Edging Higher This Afternoon
MT
05/10Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
BU
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Financials (USD)
Sales 2022 57 870 M - -
Net income 2022 15 443 M - -
Net Debt 2022 17 730 M - -
P/E ratio 2022 15,1x
Yield 2022 3,02%
Capitalization 233 B 233 B -
EV / Sales 2022 4,34x
EV / Sales 2023 4,26x
Nbr of Employees 67 500
Free-Float 70,6%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 92,32 $
Average target price 95,54 $
Spread / Average Target 3,49%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Dave Williams EVP, Chief Information & Digital Officer
Lisa LeCointe-Cephas Chief Ethics & Compliance Officer, SVP
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.20.46%233 459
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807